 |
PDBsum entry 4zyc
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Discovery of dihydroisoquinolinone derivatives as novel inhibitors of the p53-Mdm2 interaction with a distinct binding mode.
|
 |
|
Authors
|
 |
F.Gessier,
J.Kallen,
E.Jacoby,
P.Chène,
T.Stachyra-Valat,
S.Ruetz,
S.Jeay,
P.Holzer,
K.Masuya,
P.Furet.
|
 |
|
Ref.
|
 |
Bioorg Med Chem Lett, 2015,
25,
3621-3625.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Blocking the interaction between the p53 tumor suppressor and its regulatory
protein MDM2 is a promising therapeutic concept under current investigation in
oncology drug research. We report here the discovery of the first
representatives of a new class of small molecule inhibitors of this
protein-protein interaction: the dihydroisoquinolinones. Starting from an
initial hit identified by virtual screening, a derivatization program has
resulted in compound 11, a low nanomolar inhibitor of the p53-MDM2 interaction
showing significant cellular activity. Initially based on a binding mode
hypothesis, this effort was then guided by a X-ray co-crystal structure of MDM2
in complex with one of the synthesized analogs. The X-ray structure revealed an
unprecedented binding mode for p53-MDM2 inhibitors.
|
 |
|
|
|
|
 |